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Hair growth is associated with pronounced vascular-en-
dothelial-growth-factor-induced perifollicular angio-
genesis, whereas the catagen regression phase is
characterized by apoptosis-driven blood vessel regres-
sion. The biologic relevance of endogenous inhibitors
of angiogenesis in the control of hair cycling, however,
has remained unknown.We studied the expression and
biologic role of the angiogenesis inhibitor thrombos-
pondin-1 (TSP-1) during the induced adult hair follicle-
cycle in wild-type, TSP-1 de¢cient, and TSP-1
overexpressing transgenic mice. TSP-1 expression was
absent from hair bulb and dermal papilla cells during
early to mid-anagen but was highly upregulated
throughout the catagen involution phase. In TSP-1
de¢cient mice, the follicle growth phase was signi¢-
cantly prolonged, associated with increased perifollicu-
lar vascularization and vascular proliferation.
Conversely, hair follicle growth was delayed in K14/
TSP-1 transgenic mice that expressed high levels of
TSP-1 in outer root sheath keratinocytes, associated
with reduced perifollicular vascularization. These ef-
fects were most probably mediated via its antiangio-
genic e¡ects because TSP-1 did not a¡ect the growth
of cultured murine vibrissae in the absence of a func-
tional vascular system. These results identify a critical
role of TSP-1 in the induction of anagen follicle involu-
tion, with potential implications for the therapeutic
modulation of hair follicle growth. Key words: TSP-1/
angiogenesis/VEGF. J Invest Dermatol 120:14 ^19, 2003
T
he hair follicle undergoes a life-long cyclic transfor-
mation from the resting phase (telogen) to the
growth phase (anagen), associated with rapid
proliferation of follicular keratinocytes and with
elongation and thickening of the hair shafts, followed
by the regression phase (catagen) that leads to involution of hair
follicles (Chase, 1954; Hardy, 1992). These changes involve rapid
remodeling of both epithelial and dermal components and have
led to the establishment of the murine hair follicle cycle as a
prime model for studies of epithelial^mesenchymal interactions,
leading to the identi¢cation of several important molecular med-
iators that control epithelial morphogenesis and growth (Paus
and Cotsarelis, 1999).We have previously reported a pronounced
increase in perifollicular vascularization during the anagen
growth phase, accompanied by upregulation of vascular endothe-
lial growth factor (VEGF) mRNA expression in follicular kerati-
nocytes of the outer root sheath (Yano et al, 2001). Conversely,
during the catagen follicular involution phase, a rapid regression
of perifollicular blood vessels is associated with downregulation
of follicular VEGF expression (Yano et al, 2001). Moreover, en-
hanced levels of VEGF in outer root sheath keratinocytes resulted
in accelerated follicle growth and in increased thickness of hair
follicles and hair shafts in K14/VEGF transgenic mice, whereas
systemic inhibition of VEGF led to a reduced thickness of hair
follicles (Yano et al, 2001).
During the catagen involution phase, hair follicles undergo a
highly controlled process of involution that re£ects a burst of
programmed cell death (apoptosis) of follicular keratinocytes
and of perifollicular endothelial cells (Paus and Cotsarelis, 1999;
Mecklenburg et al, 2000; Yano et al, 2001). Our previous ¢ndings
suggested that the regression of perifollicular blood vessels might
represent a key factor that triggers the regression of hair follicles,
resulting in reduced nutritional supply of proliferating hair ma-
trix cells (Yano et al, 2001). Importantly, reduced vascularization
of hair follicles has been suggested to play a critical role in disor-
ders characterized by hair loss (Levy-Frankel, 1931; Beurey et al,
1971; Goldman et al, 1995), including androgenetic alopecia (male
pattern baldness), which is associated with progressive shortening
of successive anagen cycles and with miniaturization of geneti-
cally predisposed follicles (Cormia and Ernyey, 1961). Whereas
the vascular expansion during anagen is probably due to upregu-
lation of follicular VEGF expression, it has remained unknown
whether endogenous inhibitors of angiogenesis might contribute
to the vascular regression during catagen, and whether angiogen-
esis inhibition might represent a key event in the induction of
hair follicle involution.
Thrombospondin-1 (TSP-1) is a 450 kDa matricellular protein
that inhibits endothelial cell proliferation and migration in vitro
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and angiogenesis associated with tumor growth and granulation
tissue formation in vivo (Tolsma et al, 1993; Bleuel et al, 1999;
Streit et al, 1999; 2000; Bornstein, 2001). TSP-1 is expressed in hu-
man and murine skin and contributes to the normal quiescence
of the cutaneous vasculature (Detmar, 2000). To directly investi-
gate the biologic role of TSP-1 in the control of hair follicle re-
gression and vascular involution during catagen, we studied the
induced adult hair follicle cycle in transgenic mice overexpressing
TSP-1 in outer sheath follicular keratinocytes (Streit et al, 2000;
Hawighorst et al, 2002; Yano et al, 2002) and in TSP-1 de¢cient
mice (Lawler et al, 1998).
Here, we report that TSP-1 mRNA and protein expression are
highly upregulated in the dermal papilla and in epithelial cells
during the catagen and telogen phases, whereas TSP-1 expression
is absent from the hair bulb during the anagen growth phase. Im-
portantly, transgenic overexpression of TSP-1 in follicular kerati-
nocytes resulted in retarded hair growth, associated with
decreased perifollicular vascularization. Conversely, TSP-1 de¢-
cient mice showed a prolongation of the anagen growth phase
with increased perifollicular vascularization, accompanied by in-
creased proliferation of perifollicular endothelial cells and hair
matrix cells. Together with the absence of direct e¡ects of TSP-1
in vibrissa organ cultures, our results identify a major role of
TSP-1-mediated angiogenesis inhibition in the control of hair
growth and cycling.
METHODS
Induced adult hair follicle cycle The adult hair follicle cycle was
induced in the back skin of 8-wk-old female C57BL/6 mice (Charles
River Laboratories, Wilmington, MA) by depilation as described
previously (Paus et al, 1990), resulting in a synchronized induction of
anagen follicle growth. Tissue samples were obtained at days 1, 3, 5, 8, 12,
15, 18, 19, 20, and 22 after depilation as described previously (three mice per
time point), encompassing hair development from early anagen to telogen
(Yano et al, 2001). Back skin was harvested parallel to the paravertebral line
and the distinct phases of hair follicle development were determined as
described earlier (Dry, 1926; Hardy, 1992). Skin samples were either snap
frozen in liquid nitrogen or ¢xed in 4% paraformaldehyde and
embedded in para⁄n as described previously (Streit et al, 2000). All
animal studies were approved by the Massachusetts General Hospital
Subcommittee on Research Animal Care.
Hair follicle cycle studies in TSP-1 transgenic mice and in TSP-1
de¢cient mice TSP-1 transgenic mice were established by using a
keratin 14 (K14) promoter expression cassette to target human TSP-1
expression to basal epidermal keratinocytes and outer root sheath
keratinocytes of hair follicles. The establishment and the phenotypic
characterization of TSP-1 transgenic mice have been previously reported
(Streit et al, 2000). The induced hair follicle cycle was studied in 8-wk-old
TSP-1 transgenic mice (n¼ 30) and in age-matched wild-type littermates
(n¼ 30 per group) as described above. Hair follicle cycling was also
investigated in TSP-1 de¢cient mice (Lawler et al, 1998) and their wild-
type controls (n¼10 per group).
Immunohistochemistry and computer-assisted morphometric
vessel analysis Immunohistochemical stainings were performed on 7
mm frozen sections as described previously (Streit et al, 2000), using a
monoclonal rat antimouse CD31 antibody (Pharmingen, San Diego, CA)
and a secondary antirat IgG antibody labeled with AlexaFluor488
(Molecular Probes, Eugene, OR). Representative sections obtained from
three mice for each time point were analyzed, using a Nikon E-600
microscope (Nikon, Melville, NY). Images were captured with a Spot
digital camera (Diagnostic Instruments, Sterling Heights, MI) and
morphometric analyses were performed using the IP LAB software
(Scanalytics, Fairfax, VA) as described previously (Streit et al, 1999). Three
di¡erent ¢elds in each section were examined at 60magni¢cation, and
the average vessel size and the relative area occupied by blood vessels were
determined within an area of 30 mm distance of individual hair follicles as
described previously (Yano et al, 2001). The two-sided unpaired t test was
used to analyze di¡erences between the di¡erent genotypes. Endothelial
cell proliferation was studied by intraperitoneal injection of mice with 5-
bromodeoxyuridine (BrdU; 250 mg per kg of body weight) 2 h prior to
sacri¢ce, followed by double immuno£uorescence staining with anti-BrdU
(Pharmingen) and anti-CD31 antibodies (Streit et al, 2000).
Measurement of hair follicle length Hematoxylineosin stains were
performed on 7 mm frozen sections of tissues obtained from the di¡erent
stages of the induced adolescent hair follicle cycle (three mice each per time
point). Five representative sections for each sample were analyzed. The
length of hair follicles was measured as the distance from the bottom of
hair bulbs with clearly visible dermal papilla to the epidermis (50 hair
follicles for each time point), using the IP LAB software. Statistical
analysis was performed using the two-sided unpaired Student’s t test.
In situ hybridization In situ hybridization was performed on 5 mm
para⁄n sections as described previously (Streit et al, 2000). Sense and
antisense RNA probes to human TSP-1 were transcribed from a
pBluescript II KSþvector containing a 240 bp PCR fragment of the
coding region of human TSP-1. This probe recognizes both mouse and
human TSP-1 (Streit et al, 2000). Transcription reactions were carried out
using the Riboprobe Gemini II kit (Promega Madison, WI) in the
presence of (a-35S) UTP. TSP-1 mRNA expression was quanti¢ed in
sections obtained from three mice for each time point by counting
individual photographic grains over follicular keratinocytes as described
by Brown et al (1995), and samples were scored as negative (0^1 grains per
cell; score 0), weakly positive (2^5 grains per cell; score 1), moderately
positive (6^10 grains per cell; score 2), or strongly positive (410 grains per
cell; score 3). Data are shown as percentage of maximum score.
Vibrissa organ culture Whisker pads were isolated from 5-wk-old
female C57/BL mice as described previously (Yano et al, 2001) and were
shortly immersed in 70% ethanol in phosphate-bu¡ered saline, followed
by incubation inWilliam’s E medium containing 400 U per ml penicillin,
400 mg per ml streptomycin, and 1 mg per ml fungizone (Life Sciences
Rockville, MD) for 10 min. Vibrissa follicles in the early or mid-anagen
growth phase were isolated under a dissecting microscope, and the part of
the hair shaft that extended over the epidermal surface was cut o¡. Follicles
were then plated on nylon membranes (ICN, Irvine, CA) in serum-free
William’s E medium alone (n¼ 8), in medium containing 10 mg per ml
humanTSP-1 (n¼ 7), or in medium containing 10 ng per ml transforming
growth factor b2 (n¼ 8; Sigma, St. Louis, MO). Media were replaced by
fresh medium every 2 d, and follicles were incubated over a total period of
7 d. After 7 d, the length of the outgrowing hair shafts was determined by
image analysis of digital pictures, using the IP LAB software. Data are
expressed as means7SD of in vitro hair growth; statistical analyses were
performed using the two-sided unpaired Student’s t test.
RESULTS
Upregulation of TSP-1 mRNA expression during the
catagen follicle involution phase In situ hybridization studies
revealed low levels of TSP-1 mRNA expression in follicular
keratinocytes of the outer root sheath during the anagen growth
Figure1. Upregulation of TSP-1 expression during catagen. In situ
hybridization with TSP-1 antisense riboprobe reveals moderate TSP-1
mRNA expression in follicular keratinocytes of the outer root sheath (ar-
rows), but not in the hair bulb, during the anagen follicle growth phase in
wild-type mice (A). In contrast,TSP-1 expression was strongly upregulated
in the dermal papilla and the epithelial strand throughout the catagen
phase (days 18 and 19) (B, C) and was maintained during the telogen resting
phase (D). Sense control hybridizations demonstrate low background sig-
nal (EG). Scale bars: 50 mm.
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phase (Fig 1A), whereas no signal was detected in the hair bulb
or the dermal papilla. In contrast, TSP-1 expression was
upregulated in dermal papilla cells and in the epithelial strand
throughout the catagen involution phase (days 18 and 19)
(Fig 1B, C). In telogen follicles, strong TSP-1 mRNA expression
was predominantly found in the lower part of the hair follicle
(Fig 1D). Numerous apoptotic follicular keratinocytes and
several apoptotic perifollicular endothelial cells were found
during the catagen involution phase (data not shown).
We next evaluated whether enhanced TSP-1 expression levels
during the hair follicle cycle were inversely related to the extent
of perifollicular vascularization. To this end, we performed a
semiquantitative analysis of TSP-1 mRNA expression, as
assessed by in situ hybridization during the distinct phases of the
hair follicle cycle, and temporally related the TSP-1 expres-
sion levels with the quantitative analysis of perifollicular
vascularization. Whereas TSP-1 expression levels were low
during the vascular-rich anagen growth phase from day 1 to day
12, at day 19 TSP-1 expression levels raised sharply, associated
with a decrease of perifollicular vascularization (Fig 2). These
analyses con¢rmed an inverse relation between TSP-1 expression
levels and the extent of perifollicular vascularization (Fig 2),
suggesting a role of TSP-1-mediated angiogenesis inhibition
during hair follicle involution.
Impaired hair development in late anagen in K14/TSP-1
transgenic mice To directly examine the in vivo e¡ect of TSP-
1 on hair growth and cycling, we studied the induced adult hair
follicle cycle in transgenic mice with selective overexpression of
TSP-1 in basal epidermal keratinocytes and outer root sheath
keratinocytes and in wild-type littermates. No major di¡erences
in hair regrowth were observed between the two genotypes
during the ¢rst 8 d after depilation. After 12 d,TSP-1 transgenic
mice showed signi¢cantly impaired hair regrowth with few
visible hair shafts, compared with clearly visible hair growth in
wild-type littermates (Fig 3A, B). No major macroscopic
di¡erences between the two groups were found after 15 d. By
histologic analysis, no major di¡erences in the length of hair
follicles were observed until day 8 (mid-anagen). At day 12,
however, we found a signi¢cant 37.8% decrease (po0.001) of
hair follicle length in TSP-1 transgenic mice (Fig 3C, D, G),
compared with wild-type mice. No further elongation of hair
follicles was detected in TSP-1 transgenic mice during the late
anagen phase (Fig 3E, F, G).
Decreased perifollicular vascularization in K14/TSP-1
transgenic mice To investigate whether the delay and
reduction of hair follicle growth in TSP-1 transgenic mice was
associated with a suppression of perifollicular vascularization, we
performed a computer-assisted image analysis of tissue sections
stained for the endothelial junction molecule CD31 (Dejana
et al, 1995). At day 8 after depilation, we found a 48.2% decrease
(po0.001) in vessel size (Fig 4C) and a 20.2% decrease (po0.05)
in the total area occupied by vessels (Fig 4D) in K14/TSP-1
transgenic mice compared with wild-type littermates. These
changes were even more pronounced after 12 d (late anagen Fig
4A and B), with a 50.2% decrease (po0.001) in vessel size
(Fig 4C) and a 46.4% decrease (po0.001) in vessel area (Fig 4D)
in K14/TSP-1 transgenic mice. No major di¡erences between the
two genotypes were detected at later stages of the hair follicle
cycle. Together, these results suggested that normal follicle
development during the anagen growth phase is dependent on
su⁄cient vascular support, and that suppression of follicular
vascularization byTSP-1 suppressed hair follicle growth.
Delayed onset of catagen follicle involution in TSP-1
de¢cient mice The upregulation of TSP-1 expression during
the late anagen phase and throughout catagen and telogen
suggested that TSP-1 might play a major role in the induction of
catagen follicle involution. Therefore, we next studied the hair
Figure 2. In situ hybridization revealed an inverse correlation of
TSP-1 mRNA expression levels (¢lled circles) by dermal papilla cells
and perifollicular angiogenesis. Relative vessel area (open circles) is ex-
pressed as a percentage of the maximum vessel area detected during late
anagen (day 12; compare to Fig 3C).
Figure 3. Impaired hair follicle growth in TSP-1 transgenic mice.
At 12 d after depilation, hair regrowth was clearly visible in wild-type mice
(A), but not in K14/TSP-1 transgenic mice (B). Histologic analysis reveals
reduced length of anagen hair follicles in K14/TSP-1 transgenic mice (D) at
this time point, compared with wild-type mice (C). At the onset of catagen
involution (day 18), hair follicles were still shorter inTSP-1 transgenic mice
(F) than in wild-type mice (E). (C)(F), Hematoxylineosin stains; bars,
200 mm. (G) Morphometric analysis revealed a signi¢cant decrease of
anagen hair follicle length in K14/TSP-1 transgenic mice at day 12 after
depilation (po0.0001). Mean values7 SD; n¼ 3 per time point.
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follicle cycle in mice with targeted gene disruption of the TSP-1
gene. We found comparable growth of hair follicles in TSP-1
de¢cient and in wild-type mice during the anagen growth phase
(Fig 5A, B). The onset of catagen involution was signi¢cantly
delayed in TSP-1 de¢cient mice, however. Whereas all follicles
had initiated catagen involution at day 19 in wild-type mice,
only anagen follicles with a clearly recognizable dermal papilla
were detected in TSP-1 de¢cient mice at this time point
(Fig 5C, D). After 21 d, catagen involution was also detectable
in TSP-1 de¢cient mice (Fig 5F); however, the follicle length
was still signi¢cantly increased (po0.001) compared with wild-
type mice (Fig 5E, F). After 22 d, all follicles in wild-type and
in TSP-1 de¢cient mice were in the telogen resting phase.
Increased perifollicular vascularization in TSP-1 de¢cient
mice Analysis of CD31-stained tissue sections revealed
elongated and nlarged perifollicular blood vessels at day 19 in
TSP-1 de¢cient mice, compared with small and fragmented
vessels in wild-type mice. By quantitative image analysis of
CD31-stained vessels, no major di¡erences in vessel size and
cutaneous area covered by blood vessels were observed until day
12 after depilation. We found a 110.3% increase (po0.001) in
vessel size (Fig 6C) and a 72.5% increase (po0.05) in total vessel
area (Fig 6D) during catagen at day 19, however, and a
60.3% increase (po0.001) in vessel size (Fig 6C) and a
20.5% increase (n.s.) in vessel area (Fig 6D) at day 21 in TSP-1
de¢cient mice, compared with wild-type littermates. Double
immuno£uorescence stains for CD31 and for the proliferation
marker BrdU revealed persistent endothelial cell proliferation in
TSP-1 de¢cient mice at day 19 (Fig 6B), whereas no proliferating
endothelial cells were detected in wild-type follicles that had
already undergone catagen involution at this time point (Fig 6A).
The di¡erences in vascularization between the two genotypes at
day 19 were probably due to the prolongation of anagen growth
in TSP-1 de¢cient mice, because no signi¢cant di¡erences in the
perifollicular vascularization were found in anagen phase follicles
(Fig 6D).
Absence of TSP-1 e¡ects on hair growth and follicle size in
vibrissa follicle cultures in vitro To investigate whether the
observed inhibitory e¡ects of TSP-1 on hair growth might have
been mediated, in addition to its inhibitory e¡ects on
perifollicular angiogenesis, by direct e¡ects of TSP-1 on hair
follicle cells, we isolated mouse vibrissae and investigated hair
growth in organ cultures in vitro, in the absence of a functioning
vascular system. In organ culture, untreated mouse vibrissae
showed an average hair shaft outgrowth of approximately 2.3
mm over a period of 7 d (Fig 7). Addition of 50 ng per ml
transforming growth factor b to vibrissa cultures, used as a
positive control, resulted in a signi¢cant (po0.01) inhibition of
hair shaft growth, demonstrating the sensitivity of hair growth
to inhibition in this experimental system (Fig 7). In contrast,
addition of TSP-1 did not in£uence the hair growth rate in
organ culture, suggesting that a functional perifollicular vascular
Figure 4. Diminished perifollicular angiogenesis in TSP-1
transgenic mice. CD31 immunostains (red) of wild-type (A) and TSP-1
transgenic (B) mice demonstrate diminished perifollicular vascularization
of anagen follicles (day 12) in TSP-1 transgenic mice. Scale bars: 100 mm.
Quantitative image analysis of CD31-stained vessels revealed a signi¢cantly
decreased average vessel size (po0.001) at 8 and 12 d after depilation (C) in
TSP-1 transgenic mice (¢lled bars) compared with wild-type mice (open bars)
and a signi¢cant decrease of the relative area covered by vessels (D) at days
8 and 12 in K14/TSP-1 transgenic mice. npo0.05; nnnpo0.001. Mean values
7 SD; n¼ 3 per time point.
Figure 5. Prolonged anagen hair growth in TSP-1 de¢cient mice.
No major di¡erences in the length of hair follicles were detected in TSP-1
de¢cient mice and wild-type mice until day 12 of the induced hair cycle
(A, B). At day 19, wild-type follicles had initiated catagen involution (C),
whereas TSP-1 de¢cient follicles were still in the anagen growth phase (D).
After 21 d, only catagen follicles were detected in both genotypes (E, F),
although TSP-1 de¢cient follicle length was still increased over wild-type
follicles (G). Morphometric analysis revealed a signi¢cant increase of hair
follicle length in TSP-1 de¢cient mice at days 19 and 21 after depilation.
nnnpo0.001. Mean values7 SD; n¼ 3 per time point. Scale bar: 100 mm.
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system is needed in order for TSP-1 to exert its inhibitory e¡ects
on hair growth.
DISCUSSION
Previously, we have reported that murine hair follicle growth is
associated with pronounced perifollicular angiogenesis and
VEGF expression by follicular keratinocytes of the outer root
sheath (Yano et al, 2001). Moreover, increased VEGF levels in
K14/VEGF transgenic mice resulted in increased hair shaft and
follicle size, whereas systemic blockade of VEGF impaired hair
follicle growth (Yano et al, 2001).The biologic role of endogenous
inhibitors of angiogenesis for hair follicle growth and cycling has
remained unknown, however. Based on our previous identi¢ca-
tion of TSP-1 as a major endogenous inhibitor of skin angiogen-
esis (Detmar, 2000; Streit et al, 2000; Hawighorst et al, 2002;
Yano et al, 2002), we hypothesized that TSP-1 might also play an
important role in the regulation of cyclic angiogenesis associated
with hair follicle growth and involution. Semiquantitative in situ
hybridization studies revealed that TSP-1 mRNA expression was
relatively low during the anagen growth phase but was strongly
upregulated in the dermal papilla and in follicular epithelial cells
at the end of anagen and throughout the catagen involution phase
and the telogen resting phase of the follicle. The inverse relation
of TSP-1 mRNA expression levels with the levels of perifollicu-
lar angiogenesis suggests that TSP-1 represents a major antiangio-
genic stimulus responsible for vascular involution during the
catagen follicle involution phase.
To directly evaluate the biologic consequences of enhanced
TSP-1 expression for hair growth, we analyzed the induced ado-
lescent hair follicle cycle in our previously characterized trans-
genic mouse model for the selective overexpression of TSP-1 in
the epidermis and outer root sheath follicular keratinocytes, using
a K14 promoter to target transgene expression (Streit et al, 2000).
We have previously reported decreased vascularization of granu-
lation tissue during wound healing (Streit et al, 2000), reduced
ultraviolet-B-induced cutaneous photodamage (Yano et al, 2002),
and diminished epithelial carcinogenesis (Hawighorst et al, 2002)
in these mice; however, hair growth had not been studied in
detail. Our ¢ndings that targeted overexpression of TSP-1 in
follicular keratinocytes resulted in delayed and diminished
hair regrowth, associated with diminished perifollicular vascular-
ization and increased levels of endothelial apoptosis, provide the
¢rst direct evidence that endogenous inhibitors of angiogenesis
negatively regulate hair growth. Because TSP-1 treatment did
not a¡ect hair growth in organ cultures of mouse vibrissae, in
the absence of a functional vascular system, our results suggest
that the e¡ects of TSP-1 are predominantly mediated through in-
hibition of perifollicular angiogenesis rather than by direct e¡ects
on hair follicles. These ¢ndings are in agreement with our pre-
vious results that systemic blockade of the angiogenesis factor
VEGF with neutralizing antibody caused impaired anagen hair
growth and decreased angiogenesis (Yano et al, 2001).We cannot
exclude the possibility that TSP-1, at doses higher than those
tested (10 mg per ml), might a¡ect hair growth in vibrissa cul-
tures, however, and that hair follicles might react di¡erently to
TSP-1, compared with vibrissa follicles. Moreover, because the
localization of TSP-1 receptors in keratinocytes of the regressing
hair follicles is unknown, potential direct e¡ects of TSP-1 on in-
trafollicular cells cannot be completely ruled out.
The important role of TSP-1 in the control of hair follicle
cycling was con¢rmed in additional studies on TSP-1 de¢cient
mice that showed delayed induction of the catagen involution
phase associated with maintained perifollicular angiogenesis, in-
dicating that TSP-1 is a major part of the molecular program that
initiates catagen follicle involution. In contrast to other mediators
such as transforming growth factor b that have been previously
Figure 6. Increased perifollicular vascularization at day 19 in TSP-1
de¢cient mice. Double immuno£uorescence stains for CD31 (red) and
the proliferation marker BrdU (green) revealed proliferating endothelial
cells (arrows) in the skin of TSP-1 de¢cient mice (B), but not in wild-type
mice (A), at day 19 of the hair cycle. Scale bar: 100 mm. Increased perifolli-
cular vascularization at day 19 in TSP-1 de¢cient mice. Computer-assisted
morphometric analysis of CD31-stained sections revealed a signi¢cant in-
crease (po0.001) in perifollicular vessel size (C) and relative vessel area (D)
at day 19 in TSP-1 de¢cient mice (¢lled bars), compared with wild-type lit-
termates (open bars). npo0.05; nnnpo0.001. Mean values 7 SD; n¼ 3 per
time point.
Figure 7. Absence of e¡ects of TSP-1 treatment on the in vitro hair
growth rate in mouse vibrissa organ cultures. Quantitative analysis of
in vitro hair growth demonstrates signi¢cant inhibition of in vitro hair
growth by 50 ng per ml transforming growth factor b (positive control)
but lack of e⁄ciency of TSP-1 (10 mg per ml) treatment. Data are expressed
as mean7SD. n.s., no signi¢cant di¡erences; nnpo0.01.
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shown to be involved in the catagen hair involution (Foitzik et al,
2000), however,TSP-1 does not appear to directly inhibit hair fol-
licle growth. Although the duration of the anagen growth phase
was prolonged in TSP-1 de¢cient mice, we found that hair folli-
cles had reached the telogen phase in both genotypes at day 22,
suggesting that additional signals are involved in the control of
the duration of the complete hair follicle cycle. Our recent studies
suggest that the related angiogenesis inhibitor TSP-2 is also upre-
gulated during catagen (unpublished results); therefore,TSP-2 ex-
pression might have partially compensated for the absence of
TSP-1 in our studies. Future investigations in mice de¢cient for
both TSP-1 and TSP-2 should provide valuable insights into the
relative contribution of the two molecules to hair follicle cycle
control.
Decreased VEGF mRNA expression was detected in human
hair follicles in androgenetic alopecia (Goldman et al, 1995), and
several previous studies have reported diminished follicular vas-
cularization in conditions associated with impaired hair growth
in humans (Goldman et al, 1995). Our results warrant further stu-
dies to investigate whether endogenous angiogenesis inhibitors
such asTSP-1might also be involved in human diseases associated
with hair loss. In summary, our results establish an important
functional role of TSP-1 in hair biology, and they provide addi-
tional support for our previous proposal that normal hair growth
and cycling are dependent on su⁄cient perifollicular angiogen-
esis (Yano et al, 2001). Because TSP-1 was found to play a critical
role in the induction of catagen follicle regression through its in-
hibitory e¡ects on angiogenesis, these ¢ndings identify TSP-1
as a potential new target for therapies aimed at modulating hair
follicle growth.
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